Skip to main content
. 2020 Nov 2;20(12):1–134.

Table 1:

Characteristics of the Included Study

Author, Year Study Design and Methods Participants Intervention Comparator Outcomes
Koek et al, 200928 Pragmatic, multicentre, single-blinded randomized controlled noninferiority trial 196 people, aged ≥ 18 years, with psoriasis who were clinically eligible for NB-UVB phototherapy Home NB-UVB using the TL01 home NB-UVB phototherapy unit (manufactured by Philips) Outpatient-based standard NB-UVB phototherapy Primary outcomes: SAPASI 50, PASI 50

Secondary outcomes: SAPASI 75, PASI 75, SAPASI 90, PASI 90

Quality of life: PDI, SF-36

Side effects: mild erythema, severe erythema, burning sensation, blistering

Abbreviations: NB-UVB, narrowband ultraviolet B; PASI, Psoriasis Area and Severity Index; PDI, Psoriasis Disability Index; SAPASI, Self-Administered Psoriasis Area and Severity Index; SF-36, 36-Item Short-Form Survey.